To date, the conversation around CAR-T cell therapies in cancers has focused on the most visible considerations: efficacy, toxicity and cost. But while those factors are important, another one deserves equal consideration: manufacturing.
{iframe}https://medcitynews.com/2019/01/for-car-ts-to-be-successful-figuring-out-manufacturing-is-key/{/iframe}